Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 11,652 shares at $12.07 ($141K) on 2020-05-01, disclosed to the SEC on 2020-05-05.
Open-market sale of $141k HARP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.07 | 5,826 | $70K | 50.0% |
| 2 | $12.07 | 5,826 | $70K | 50.0% |
| Total | $12.07 avg | 11,652 | $141K | 100% |
| Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |
| HARP | SELL | 2020-03-18 | $18K | — | Filing → |